PharmaCan Capital Corp Stock Toronto S.E.
Equities
MJN
CA7171151094
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
Apr. 30 | Sector Update: Consumer Stocks Slipping in Late Afternoon Trading | MT |
Apr. 30 | Cannabis Stocks Jump on Report DEA to Reclassify Marijuana as Less Dangerous Drug | MT |
Sales 2024 * | 138M 101M | Sales 2025 * | 165M 120M | Capitalization | 1.39B 1.02B |
---|---|---|---|---|---|
Net income 2024 * | -17M -12.41M | Net income 2025 * | -15M -10.95M | EV / Sales 2024 * | 1.48 x |
Net cash position 2024 * | 1.19B 867M | Net cash position 2025 * | 1.19B 870M | EV / Sales 2025 * | 1.21 x |
P/E ratio 2024 * |
-59
x | P/E ratio 2025 * |
-40.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.38% |
Latest transcript on PharmaCan Capital Corp
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 37 | 15-11-05 | |
James Holm
DFI | Director of Finance/CFO | 41 | 22-11-13 |
Arye Weigensberg
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 48 | 21-06-24 | |
James D. Rudyk
BRD | Director/Board Member | 57 | 18-01-31 |
Jason Adler
BRD | Director/Board Member | 52 | 16-07-11 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |
- Stock Market
- Equities
- CRON Stock
- MJN Stock